Pharma’s Cutting Edge

Here’s a follow-up story from the Washington Post on the preamble to the new labeling guidance that aims to limit states’ rights to sue drug manufacturers.

January 19th, 2006 | Category: FDA, For Investors, Public Perceptions | Subscribe to comments | Leave a comment | Trackback URL